Dr Sophy Shih is a senior health economist with expertise in economic evaluation and health service research and is leading a health economics research team in child health and precision medicine. She has extensive experience of designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Dr Shih was trained in health economics, public health and biomedical science. She has worked on a broad range of topics including viral infection, rare genetic disorders, cancers, diabetes, psycho-oncology, and disability with a focus on prevention and screening.
In 2019, Dr Shih joined the Kirby Institute and the Centre for Big Data Research in Health as a Senior Research Fellow/Health Economist. Her current working programs in Kirby Institute focus on HCV and HIV testing strategies and treatment uptake, specifically in scaling up point-of-care (POC) technology to enhance detection of HCV and HIV infection.
Dr Shih is also leading the health economics research for child health and precision medicine within the School of Clinical Medicine. Her current work is dedicated to health service research of a national paediatric cancer care program, i.e. ZERO Childhood Cancer personalised medicine program. Dr Shih was a subcommittee member of the Clinical Guidelines Network at Cancer Council Australia and co-authored the “Economics of Keratinocyte Cancer” chapter of the NHMRC-endorsed clinical guidelines “Clinical Practice Guidelines for Keratinocyte Cancer”.